A17G (p.Ala17Gly) variant of CALR (Calreticulin)

A17G (p.Ala17Gly) in CALR (Calreticulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

A17G (p.Ala17Gly) variant details